Search

everythinglearnresearchcommunity

for

Search:↓

Lithium therapy may cause temporary hair loss, with possible regrowth if treatment is stopped or continued.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Thallium poisoning can cause hair loss, skin rashes, and nerve damage, and can be fatal if not correctly diagnosed and treated.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Hair loss from genetics and hormones can be treated with drugs or surgery.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.